Company Filing History:
Years Active: 1998
Title: The Innovations of Mary S. Gibadlo
Introduction
Mary S. Gibadlo is a notable inventor based in Palatine, IL (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for the diagnosis and treatment of hepatitis C, a viral infection that affects millions worldwide.
Latest Patents
Mary S. Gibadlo holds a patent for "Monoclonal antibodies to hepatitis C virus and method for using same." This patent includes monoclonal antibodies that specifically bind to various proteins of the Hepatitis C Virus, including the C-100 protein, 33C protein, and CORE protein. Additionally, her patent describes hybridomas that produce these monoclonal antibodies, along with methods for their use and assay kits containing these antibodies. She has 1 patent to her name.
Career Highlights
Mary is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. Her work at Abbott has allowed her to focus on innovative solutions that address critical health challenges. Her research has contributed to advancements in the understanding and treatment of viral infections.
Collaborations
Mary has collaborated with esteemed colleagues, including Smriti U. Mehta and Jill E. Johnson. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of biotechnology.
Conclusion
Mary S. Gibadlo's contributions to the field of biotechnology, particularly through her patent on monoclonal antibodies for hepatitis C, highlight her innovative spirit and dedication to improving healthcare. Her work continues to inspire advancements in medical research and treatment options.